Upper gastrointestinal endoscopy in emergency setting for patients receiving oral anticoagulants - practice updates

Area of Science:

• Gastroenterology
• Cardiology
• Pharmacology

Background:

• Anticoagulants are crucial for cardiovascular diseases but increase gastrointestinal bleeding risk.
• Interruption of anticoagulation poses a risk of thromboembolic events.
• Lack of specific guidelines exists for managing upper gastrointestinal bleeding in anticoagulated patients.

Purpose of the Study:

• To review current management strategies for upper gastrointestinal bleeding in patients taking oral anticoagulants.
• To highlight the challenges posed by novel oral anticoagulants lacking specific antidotes.
• To emphasize the need for definitive endoscopic hemostasis.

Main Methods:

• Literature review of current practices and guidelines.
• Analysis of anticoagulant mechanisms and bleeding risks.
• Discussion of endoscopic hemostasis techniques.

Main Results:

• Standardized protocols exist for procedure-related anticoagulant interruption, but not for active bleeding management.
• Novel oral anticoagulants present challenges due to the absence of rapid reversal agents.
• Effective endoscopic hemostasis is critical for managing bleeding in these patients.

Conclusions:

• Definitive endoscopic hemostasis is paramount in managing upper gastrointestinal bleeding in patients on anticoagulation.
• Further research and guideline development are needed for optimal patient care.
• A multidisciplinary approach is essential for balancing anticoagulation needs and bleeding management.